The robot-assisted percutaneous coronary intervention (pci) market size has grown exponentially in recent years. It will grow from $27.56 billion in 2025 to $38.73 billion in 2026 at a compound annual growth rate (CAGR) of 40.5%. The growth in the historic period can be attributed to growth in coronary artery disease prevalence, limitations of manual pci precision, increasing use of catheter-based interventions, rising awareness of radiation risks, expansion of cardiac catheterization labs.
The robot-assisted percutaneous coronary intervention (pci) market size is expected to see exponential growth in the next few years. It will grow to $149.68 billion in 2030 at a compound annual growth rate (CAGR) of 40.2%. The growth in the forecast period can be attributed to advancements in robotic-assisted intervention technologies, increasing adoption of automation in cardiology, rising investment in digital healthcare infrastructure, growing demand for complex and high-risk pci procedures, supportive regulatory approvals for robotic systems. Major trends in the forecast period include rising adoption of minimally invasive cardiac procedures, growing focus on reducing radiation exposure for clinicians, increasing demand for precision and procedural accuracy, expansion of complex coronary intervention capabilities, improved patient safety and clinical outcomes.
The rising prevalence of cardiovascular diseases is expected to drive the growth of the robot-assisted percutaneous coronary intervention (PCI) market going forward. Cardiovascular diseases encompass disorders affecting the heart and blood vessels, including coronary artery disease, heart attacks, and stroke. The increase in these conditions is largely attributed to sedentary lifestyles, which contribute to obesity, hypertension, and poor cardiovascular health. Robot-assisted PCI addresses cardiovascular diseases by precisely reopening blocked or narrowed coronary arteries to restore blood flow to the heart, while minimizing procedural risks and radiation exposure, thereby improving patient outcomes. For instance, in December 2024, GOV.UK, a UK-based government agency, reported that in March 2024, nearly 2.24 million adults in England - approximately 4.4% of those aged 18 and over - had a GP-recorded diagnosis of CKD, up from 2.09 million cases the previous year. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the robot-assisted PCI market.
Leading companies in the robot-assisted percutaneous coronary intervention (PCI) market are investing in advanced robotic cardiology platforms to enhance patient safety and simplify complex coronary procedures. A robotic cardiology platform is a sophisticated system that assists cardiologists in performing precise and controlled coronary interventions while improving accuracy, reducing human error, and minimizing radiation exposure for both patients and medical personnel. For instance, in May 2023, Robocath SAS, a France-based firm specializing in robotic vascular intervention solutions, launched the R-One+. This cutting-edge robotic system allows interventional cardiologists to perform coronary angioplasties (PCI) by operating devices via an integrated command unit in the catheterization lab or control room. The R-One+ boosts precision in device handling, enhances safety for patients and staff by lowering radiation exposure, and provides more comfortable working conditions for operators. Its unveiling at the EuroPCR conference in Paris highlighted new capabilities that make PCI procedures safer and more efficient while protecting the cardiology team from radiation-related injuries. This launch underscores Robocath's dedication to advancing cardiovascular disease treatment through intelligent robotic assistance.
In April 2024, Microbot Medical, a US-based developer of robotic endovascular systems and minimally invasive vascular solutions, entered into a partnership with Corewell Health. Through this collaboration, Microbot Medical and Corewell Health aim to advance remote telesurgery by leveraging Microbot’s LIBERTY Endovascular Robotic Surgical System. Corewell Health, a US-based healthcare provider, specializes in robotic-assisted procedures and focuses on enhancing patient care in cardiovascular interventions.
Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc., AngioDynamics, Clear Surgical Inc., GE Healthcare, Canon Medical Systems, Asensus Surgical, Endovascular Robotics.
North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (pci) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robot-assisted percutaneous coronary intervention (pci) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the robot-assisted pci market by increasing costs of imported robotic components, imaging units, and precision electromechanical systems. Robotic systems and control console segments are most affected, particularly in regions such as north america and asia-pacific that rely on global supply chains for advanced medical robotics. These cost pressures have slowed procurement for some hospitals. However, tariffs have also encouraged local manufacturing, strategic sourcing, and technology partnerships, supporting long-term innovation and regional production capabilities.
The robot-assisted percutaneous coronary intervention (pci) market research report is one of a series of new reports that provides robot-assisted percutaneous coronary intervention (pci) market statistics, including robot-assisted percutaneous coronary intervention (pci) industry global market size, regional shares, competitors with a robot-assisted percutaneous coronary intervention (pci) market share, detailed robot-assisted percutaneous coronary intervention (pci) market segments, market trends and opportunities, and any further data you may need to thrive in the robot-assisted percutaneous coronary intervention (pci) industry. This robot-assisted percutaneous coronary intervention (pci) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Robot-assisted percutaneous coronary intervention (R-PCI) is a minimally invasive procedure in which robotic systems help navigate catheters, balloons, and stents to treat narrowed or blocked coronary arteries. This technology enhances precision, stability, and control, reducing human error while also minimizing radiation exposure for both patients and healthcare staff. The approach aims to improve procedural safety, efficiency, and overall clinical outcomes.
The primary components of robot-assisted PCI include robotic systems, catheters and guidewires, and control consoles. Robotic systems are advanced machines that enable physicians to remotely manipulate guidewires, balloons, and stents from a protected workstation. R-PCI is utilized in procedures such as coronary angioplasty, stent placement, and thrombectomy, and serves end users including hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and other healthcare facilities.
The robot-assisted percutaneous coronary intervention (PCI) market consists of revenues earned by entities by providing services such as robotic catheter navigation, remote-controlled stent placement, real-time imaging integration, and procedural planning support. The market value includes the value of related goods sold by the service provider or included within the service offering. The robot-assisted percutaneous coronary intervention (PCI) market also includes sales of radiation shielding accessories, robotic arm components, monitoring and display units, integration interfaces, and sterile disposable kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The robot-assisted percutaneous coronary intervention (pci) market size is expected to see exponential growth in the next few years. It will grow to $149.68 billion in 2030 at a compound annual growth rate (CAGR) of 40.2%. The growth in the forecast period can be attributed to advancements in robotic-assisted intervention technologies, increasing adoption of automation in cardiology, rising investment in digital healthcare infrastructure, growing demand for complex and high-risk pci procedures, supportive regulatory approvals for robotic systems. Major trends in the forecast period include rising adoption of minimally invasive cardiac procedures, growing focus on reducing radiation exposure for clinicians, increasing demand for precision and procedural accuracy, expansion of complex coronary intervention capabilities, improved patient safety and clinical outcomes.
The rising prevalence of cardiovascular diseases is expected to drive the growth of the robot-assisted percutaneous coronary intervention (PCI) market going forward. Cardiovascular diseases encompass disorders affecting the heart and blood vessels, including coronary artery disease, heart attacks, and stroke. The increase in these conditions is largely attributed to sedentary lifestyles, which contribute to obesity, hypertension, and poor cardiovascular health. Robot-assisted PCI addresses cardiovascular diseases by precisely reopening blocked or narrowed coronary arteries to restore blood flow to the heart, while minimizing procedural risks and radiation exposure, thereby improving patient outcomes. For instance, in December 2024, GOV.UK, a UK-based government agency, reported that in March 2024, nearly 2.24 million adults in England - approximately 4.4% of those aged 18 and over - had a GP-recorded diagnosis of CKD, up from 2.09 million cases the previous year. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the robot-assisted PCI market.
Leading companies in the robot-assisted percutaneous coronary intervention (PCI) market are investing in advanced robotic cardiology platforms to enhance patient safety and simplify complex coronary procedures. A robotic cardiology platform is a sophisticated system that assists cardiologists in performing precise and controlled coronary interventions while improving accuracy, reducing human error, and minimizing radiation exposure for both patients and medical personnel. For instance, in May 2023, Robocath SAS, a France-based firm specializing in robotic vascular intervention solutions, launched the R-One+. This cutting-edge robotic system allows interventional cardiologists to perform coronary angioplasties (PCI) by operating devices via an integrated command unit in the catheterization lab or control room. The R-One+ boosts precision in device handling, enhances safety for patients and staff by lowering radiation exposure, and provides more comfortable working conditions for operators. Its unveiling at the EuroPCR conference in Paris highlighted new capabilities that make PCI procedures safer and more efficient while protecting the cardiology team from radiation-related injuries. This launch underscores Robocath's dedication to advancing cardiovascular disease treatment through intelligent robotic assistance.
In April 2024, Microbot Medical, a US-based developer of robotic endovascular systems and minimally invasive vascular solutions, entered into a partnership with Corewell Health. Through this collaboration, Microbot Medical and Corewell Health aim to advance remote telesurgery by leveraging Microbot’s LIBERTY Endovascular Robotic Surgical System. Corewell Health, a US-based healthcare provider, specializes in robotic-assisted procedures and focuses on enhancing patient care in cardiovascular interventions.
Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc., AngioDynamics, Clear Surgical Inc., GE Healthcare, Canon Medical Systems, Asensus Surgical, Endovascular Robotics.
North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (pci) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robot-assisted percutaneous coronary intervention (pci) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the robot-assisted pci market by increasing costs of imported robotic components, imaging units, and precision electromechanical systems. Robotic systems and control console segments are most affected, particularly in regions such as north america and asia-pacific that rely on global supply chains for advanced medical robotics. These cost pressures have slowed procurement for some hospitals. However, tariffs have also encouraged local manufacturing, strategic sourcing, and technology partnerships, supporting long-term innovation and regional production capabilities.
The robot-assisted percutaneous coronary intervention (pci) market research report is one of a series of new reports that provides robot-assisted percutaneous coronary intervention (pci) market statistics, including robot-assisted percutaneous coronary intervention (pci) industry global market size, regional shares, competitors with a robot-assisted percutaneous coronary intervention (pci) market share, detailed robot-assisted percutaneous coronary intervention (pci) market segments, market trends and opportunities, and any further data you may need to thrive in the robot-assisted percutaneous coronary intervention (pci) industry. This robot-assisted percutaneous coronary intervention (pci) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Robot-assisted percutaneous coronary intervention (R-PCI) is a minimally invasive procedure in which robotic systems help navigate catheters, balloons, and stents to treat narrowed or blocked coronary arteries. This technology enhances precision, stability, and control, reducing human error while also minimizing radiation exposure for both patients and healthcare staff. The approach aims to improve procedural safety, efficiency, and overall clinical outcomes.
The primary components of robot-assisted PCI include robotic systems, catheters and guidewires, and control consoles. Robotic systems are advanced machines that enable physicians to remotely manipulate guidewires, balloons, and stents from a protected workstation. R-PCI is utilized in procedures such as coronary angioplasty, stent placement, and thrombectomy, and serves end users including hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and other healthcare facilities.
The robot-assisted percutaneous coronary intervention (PCI) market consists of revenues earned by entities by providing services such as robotic catheter navigation, remote-controlled stent placement, real-time imaging integration, and procedural planning support. The market value includes the value of related goods sold by the service provider or included within the service offering. The robot-assisted percutaneous coronary intervention (PCI) market also includes sales of radiation shielding accessories, robotic arm components, monitoring and display units, integration interfaces, and sterile disposable kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Characteristics
3. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Supply Chain Analysis
4. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Trends and Strategies
5. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Analysis of End Use Industries
7. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Total Addressable Market (TAM) Analysis for the Market
9. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Segmentation
10. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Regional and Country Analysis
11. Asia-Pacific Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
12. China Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
13. India Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
14. Japan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
15. Australia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
16. Indonesia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
17. South Korea Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
18. Taiwan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
19. South East Asia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
20. Western Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
21. UK Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
22. Germany Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
23. France Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
24. Italy Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
25. Spain Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
26. Eastern Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
27. Russia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
28. North America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
29. USA Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
30. Canada Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
31. South America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
32. Brazil Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
33. Middle East Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
34. Africa Robot-Assisted Percutaneous Coronary Intervention (PCI) Market
36. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Competitive Landscape and Company Profiles
37. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Other Major and Innovative Companies
40. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses robot-assisted percutaneous coronary intervention (pci) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for robot-assisted percutaneous coronary intervention (pci)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robot-assisted percutaneous coronary intervention (pci) market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Robotic Systems; Catheters And Guidewires; Control Consoles2) By Application: Coronary Angioplasty; Stent Placement; Thrombectomy
3) By End-User: Hospitals; Cardiac Catheterization Laboratories; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Robotic Systems: Electromechanical Robotic Arms; Imaging Integration Units; Robotic Drive Systems2) By Catheters And Guidewires: Coronary Guidewires; Balloon Catheters; Drug-Eluting Catheters
3) By Control Consoles: Touchscreen Interfaces; Joystick Controllers; Imaging Display Panels
Companies Mentioned: Medtronic plc; Siemens Healthineers AG; Boston Scientific Corporation; Intuitive Surgical; BIOTRONIK SE & Co. KG; MicroPort Scientific Corporation; Biosensors International Group Ltd.; OrbusNeich Medical Group Holdings Limited; Stereotaxis Inc.; Perfint Healthcare; Robocath Inc.; Meril Life Sciences Pvt. Ltd.; Abbott Laboratories; Philips Healthcare; Terumo Corporation; Asahi Intecc; Catheter Precision; Cardiobot; Remedics; meerecompany Inc.; AngioDynamics; Clear Surgical Inc.; GE Healthcare; Canon Medical Systems; Asensus Surgical; Endovascular Robotics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Robot-Assisted Percutaneous Coronary Intervention (PCI) market report include:- Medtronic plc
- Siemens Healthineers AG
- Boston Scientific Corporation
- Intuitive Surgical
- BIOTRONIK SE & Co. KG
- MicroPort Scientific Corporation
- Biosensors International Group Ltd.
- OrbusNeich Medical Group Holdings Limited
- Stereotaxis Inc.
- Perfint Healthcare
- Robocath Inc.
- Meril Life Sciences Pvt. Ltd.
- Abbott Laboratories
- Philips Healthcare
- Terumo Corporation
- Asahi Intecc
- Catheter Precision
- Cardiobot
- Remedics
- meerecompany Inc.
- AngioDynamics
- Clear Surgical Inc.
- GE Healthcare
- Canon Medical Systems
- Asensus Surgical
- Endovascular Robotics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 38.73 Billion |
| Forecasted Market Value ( USD | $ 149.68 Billion |
| Compound Annual Growth Rate | 40.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
